| 产品描述: | Bcr-Abl 抑制剂;Bcr-Abl Inhibitors;产品介绍:Radotinib (IY-5511) 是一种选择性 BCR-ABL1 酪氨酸激酶抑制剂,IC50 为 34 nM,用于治疗慢性髓性白血病。;InformationRadotinib Radotinib (IY-5511) is a selective BCR-ABL1 tyrosine kinase inhibitor with IC50 of 34 nM, used to treat Chronic Myeloid Leukemia.TargetsBCR-ABL1 34 nMIn vitroRadotinib binds BCR-ABL1 and reduces phosphorylation of CrkL, a BCR-ABL1 target protein. Radotinib also effectively inhibits the proliferation of common mutant clones of BCR-ABL1, with the exception of T315I. In AML cells, radotinib significantly decreases the cell viability, promotes differentiation, and induces CD11b expression and apoptosis. In NB4, THP-1, and Kasumi-1 cells, radotinib also induces CD11b expression, and decreases the viability.Cell Research(from reference)Cell lines:BMCs of AML and CML patients, NB4, HL60, KASUMI-1, and THP-1 cells Concentrations:~100 μM Incubation Time:72 h |